Amylyx Pharmaceuticals
The Director, Access Marketing leads the strategic development and execution of market access resources for multiple customer audiences, including payers, health systems, and patient services programs. This role is responsible for creating compliant, compelling materials that translate access strategy and evidence into actionable resources to advance patient access for the company's lead product candidate. The position involves collaborating with cross-functional teams to refine messaging, manage agency partners, and evaluate the effectiveness of access marketing initiatives.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Amylyx Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for diseases with high unmet needs, including Post-Bariatric Hypoglycemia (PBH), Wolfram Syndrome, and Amyotrophic Lateral Sclerosis (ALS). Its lead program, Avexitide, is being evaluated in the pivotal Phase 3 LUCIDITY clinical trial for PBH. Amylyx advances its pipeline using rigorous science, well-defined mechanistic rationale, and a strong commitment to the patient communities it serves.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amylyx Pharmaceuticals.
6% above the average for this role
Wall Street Zen Upgrades Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating
4 days ago
Director, Access Strategy & Marketing
Revolution Medicines
Associate Director, Market Access Strategy & Insights, HIV Prevention
Gilead Sciences
Director of U.S. Access Marketing
AstraZeneca
Director of U.S. Access Marketing
AstraZeneca
Copy Supervisor - Market Access
RevHealth
Senior Director, Field HEOR
Revolution Medicines